DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Summary for Patent: 6,307,101
|Title:||Inhibitors of metalloproteases, pharmaceutical compositions comprising same and methods of their use|
|Abstract:||Disclosed are novel inhibitors of metalloproteases, in particular matrix metalloproteases. The disclosed inhibitors are mercaptoketone and mercaptoalcohol compounds which are useful in pharmaceutical compositions and methods for treating or controlling disease states or conditions which involve tissue breakdown, for example, arthropathy, dermatological conditions, bone resorption, inflammatory diseases, and tumor invasion and in the promotion of wound healing.|
|Inventor(s):||Campbell; David A. (San Mateo, CA), Patel; Dinesh V. (Fremont, CA), Xiao; Xiao-Yi (La Jolla, CA)|
|Patent Claims:||1. A compound comprising the formula: ##STR27##
A is selected from the group consisting of C.dbd.O and CHOH;
M is selected from the group consisting of hydrogen, alkyl, substituted alkyl, aryl, and heteroaryl;
R.sup.1 is selected from the group consisting of hydrogen, alkyl, substituted alkyl, aryl, heteroaryl, arylalkyl, heteroarylalkyl, heterocyclic and heterocyclicalkyl;
R.sup.2 is hydrogen, or R.sup.1 and R.sup.2 together with the nitrogen atom to which they are attached form a heterocyclic or heteroaryl ring;
R.sup.3 is --(CH.sub.2).sub.n --V wherein n is a whole number from 0 to 4 and V is selected from the group consisting of hydrogen, alkyl, substituted alkyl, --OR, --NR.sup.12 R.sup.13, and --SR.sup.13, wherein R.sup.12 and R.sup.13 are each independently hydrogen, allyl, substituted alkyl, alkenyl, aryl, arylalkyl, --C(O)-alkyl, --C(O)-substituted alkyl, --C(O)-aryl, --C(O)-heteroaryl, heteroaryl heterocyclic, heterocyclicalkyl or heteroarylalkyl wherein, in the case of --NR.sup.12 R.sup.13, the nitrogen atom is optionally incorporated into the heteroaryl or heterocyclic ring structure; and
pharmaceutically acceptable salts thereof.
2. A pharmaceutical composition of matter comprising the compound of claim 1 in an amount effective for treating or controlling disease states associated with metalloproteases in patients in need of such treatment; and a pharmaceutically acceptable carrier, with the proviso that said metalloproteases do not include collagenase-1 and stromelysin-I.
3. A method for treating or controlling disease states associated with metalloproteases in patients in need of such treatment which method comprises administering to said patient an effective amount of the compound of claim 1, with the proviso that said metalloproteases do not include collagenase-1 and stromelysin-I.
4. A method for treating or controlling disease states or conditions involving tissue breakdown or inflammatory conditions comprising administering to a patient in need of such treatment an effective amount of the compound of claim 1.
|Applicant||Tradename||Biologic Ingredient||Dosage Form||BLA||Number||Approval Date||Patent No.||Assignee||Estimated Patent Expiration||Status||Orphan||Source|
|Advance Biofactures||SANTYL||collagenase||VIAL||101995||001||1965-06-04||Start Trial||2014-10-27||RX||search|
|>Applicant||>Tradename||>Biologic Ingredient||>Dosage Form||>BLA||>Number||>Approval Date||>Patent No.||>Assignee||>Estimated Patent Expiration||>Status||>Orphan||>Source|
|Country||Patent Number||Publication Date|
|World Intellectual Property Organization (WIPO)||9640204||Dec 19, 1996|
|World Intellectual Property Organization (WIPO)||9640738||Dec 19, 1996|
|United States of America||5831004||Nov 03, 1998|
|United States of America||5840698||Nov 24, 1998|
|United States of America||5929278||Jul 27, 1999|
|European Patent Office||0832100||Apr 01, 1998|
|>Country||>Patent Number||>Publication Date|
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.